Emeritus Professor Basil Roufogalis

Emeritus Professor
Pharmacology: School of Medical Sciences


Map

Selected grants

2015

  • Symposium of Big Data in Integrative Medicine Research; Poon J, Lam M, Loy C, Poon S, Roufogalis B, Sze D, Meng H, Wu J, Cheng Y; Office of Global Engagement/IPDF Grant.

2012

  • GeneAtlas Personal Microarray System; Richardson D, Scolyer R, Stocker R, Weninger W, Black J, Allen D, Murray M, Mason R, Twigg S, King N, Horvath L, Lovicu F, Lee C, Halliday G, Lovejoy D, Joshua D, Sharland A, Roufogalis B, Hambly B, Morris B, Bao B, Bishop A, Hibbs D, Lane D, Zhou F, Hanrahan J, Dixon K, Rendina L, Byrne M, Naylor M, Cole N, Jansson P, Dong Q, Codd R, Payne R, Assinder S, Chadban S, Fraser S, McLennan S, Suryo Rahmanto A, Lai D, Yu Y, Ju Y, Buckland M, Kovacevic Z, Saletta F, Zreiqat H, Kalinowski D, Groundwater P, Simes R, Zhang D, Boyer M, Murphy C; National Health and Medical Research Council (NHMRC)/Equipment Grants.

2011

  • Regulation and authentication of scheduled and toxic Chinese herbs in Australia; Poon J, Li G, Chan K, Roufogalis B, McLachlan A, Li K, Razmovski-Naumovsk V; University of Sydney/Research Support.

2010

  • Oxidative Stress Bioanalytical Facility; Stocker R, Hunt N, Mason R, Witting P, Roufogalis B, Lay P, Tiganis T, Davies M, Dawes I, Drummond G, Geczy C, Kachigian L, Hogg P, Lackmann M, Thomas S, Croft K, King N, Tilley L, James D; Australian Research Council (ARC)/Linkage Infrastructure, Equipment and Facilities (LIEF).

2009

  • RES: Updating information contained in The University of Sydney, Herb-Drug Interaction Database (2013-044); McLachlan A, Duke C, Roufogalis B; UnityHealth Pty Ltd/Research Support.
  • Ginger-based agents for delaying the onset of metabolic syndrome: type-2 diabetes and dyslipidemia; Roufogalis B, Tran V, Duke C; Australian Research Council (ARC)/Linkage Projects (LP).
  • Bruker APEXII X-ray diffractometer detector; Hibbs D, Roufogalis B; Clive & Vera Ramaciotti Foundation/Awards for Biomedical Research: Major Equipment.
  • Bruker APEX II CCD Detector Fourth Generation APEX II ultra-low noise CCD X-ray detector with 16 megapixel chip; Hibbs D, Roufogalis B, Murray M, Hambley T, Hanrahan J, Church W, Collins M, Johnston G, Young P, Traini D; National Health and Medical Research Council (NHMRC)/Equipment Grants.

2008

  • NICM Collaborative Centre for Traditional Chinese Medicines; Roufogalis B, Li G; National Center for Complementary Medicine/Collaborative Centre Establishment Program.
  • Plant Nutraceuticals and Bioactive Molecules: A growth opportunity for the pharmaceutical industry i; Roufogalis B, Todd M; Department of Industry, Innovation and Science/Australia-India Strategic Research Fund (AISRF).

2007

  • Quality standardisation, anti-inflammation and antidepressant activities of Hypericum species and Mo; Roufogalis B, Li G; Department of Industry, Innovation and Science/International Science Linkages: Australia-China Fund for Scientific and Technological Cooperation.
  • Characterisation of cancer stem cells in myeloma leading to novel anti-tumour drug development; Sze D, Roufogalis B, Joshua D; Cancer Council New South Wales/Research Project Grants.

2006

  • Development of New Analgesic Agents Based on Desensitization of the TRPV1 Pain Receptor; Roufogalis B; University of Sydney/Research & Development.

2005

  • Characterisation of the Interactions between alpha hydroxyketones and TRPVI; Roufogalis B, Ede N; Asthma Foundation of NSW/BLO Project.
  • Research Investigation of Panox notoginseng in treatment of diabetes complicaitons, agreement with Kelin Research Institute Ltd.; Roufogalis B; Klein Research Institute (USA)/Klein Research Institute.
  • Herbal Medicines Research; Roufogalis B, Ng K, He H; Research Donations/Default scheme.
  • 7500 Real-time PCR instrument plus software; Roufogalis B, Armour C, Collins M, Ammit A, Murray M, Hughes M; National Health and Medical Research Council (NHMRC)/Equipment Grants.

2004

  • Share in NHMRC grant A Ral Signalling Complex in VesicleTraffic with Childrens Medical Research Institute as the Lead Institute; Roufogalis B, Prud'homme R; National Health and Medical Research Council (NHMRC)/Project Grants.

2003

  • Interactions between herbal medicines and the anticoagulant warfarin; Ammit A, Duke C, McLachlan A, Roufogalis B; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Konica Medical Film Processor SRX-101A; Armour C, Collins M, Hughes M, Ammit A, Roufogalis B; National Health and Medical Research Council (NHMRC)/Equipment Grants.

2002

  • Morphine: friend or foe to cancer patients.; Roufogalis B; University of Sydney/Cancer Research Fund.
  • Synthetic derivatives of capsaicin and gingerols as analgesics acting at the vanilloid receptor; Roufogalis B, Duke C; Australian Research Council (ARC)/Discovery Projects (DP).
  • Role of flavonoids from phytomedicines in herb-drug interactions mediated by p-glycoprotein; Roufogalis B, Duke C; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Literature evaluation on possible interaction of Valeriana officinalis and lozenge ingredient benzydamine; Roufogalis B, Reed D; Roche Products Pty Limited/Research Grants.

2001

  • Medicinal uses of Phenylalknols and derivatives (Gingerol analogues); Roufogalis B; Seed Funding (BLO)/BLO Project.
  • Ral-mediated signalling pathways in neurons; Robinson P, Roufogalis B; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Clinical evaluations of herb-drug interactions and database for herb-drug interactions.; Roufogalis B; Vincent Fairfax Family Foundation/Research Grant.

2000

  • A novel GTP-binding protein with peptidase activity; Roufogalis B; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Regulation of intracellular ATP levels by stimulation of pain receptor VR-1 (capsaicin receptor); Roufogalis B, Dedov V; Australian Research Council (ARC)/Small Grants.
  • Ginger as a source of herbal medicines and new chemcial entities for the treatment of pain and inflammation; Roufogalis B, Duke C; Australian Research Council (ARC)/Strategic Partnerships with Industry - Research and Training (SPIRT).
  • Research & Development of Gynostemma pentaphyllum; Zhaoping R, Roufogalis B; Ankang Beijing University/BLO Project.

1999

  • Research and development of Gynostemma Therapeutic Products; Roufogalis B, Jordan E, Murdoch E, Orr J, De Silva S, Moore T; Herron Pharmaceuticals Pty Ltd/BLO Project.

Selected publications

Download citations: PDF RTF Endnote

Books

  • Chrubasik, S., Roufogalis, B. (2002). Phytomedicines for Respiratory Tract Diseases. Australia: Australian Pharmaceutical Publishing COmpany Ltd.
  • Duke, C., Goh, P., McLachlan, A., Roufogalis, B. (2001). Complementary Medicines. Australia: Pharmaceutical Society of Australia.

Book Chapters

  • Kota, B., Wei Teoh, A., Roufogalis, B. (2012). Pharmacology of Traditional Herbal Medicines and Their Active Principles Used in the Treatment of Peptic Ulcer, Diarrhoea and Inflammatory Bowel Disease. In Thomas Brzozowski (Eds.), New Advances in the Basic and Clinical Gastroenterology, (pp. 297-310). Croatia: InTech Publishers. [More Information]
  • Razmovski-Naumovski, V., Duke, R., Tran, V., Li, G., Tattam, B., Roufogalis, B., Duke, C. (2008). Current methods in the isolation and characterisation of saponins from Gynostemma pentaphyllum. In Francesco Epifano (Eds.), Current Trends in Phytochemistry, (pp. 283-309). Kerala, India: Research Signpost.
  • Roufogalis, B. (2002). The growth in complementary and herbal medicine. In Kong Yun-cheung (Eds.), Modern Chinese Medicine: Education , Research and Development, (pp. 19-24). Hong Kong: BMJ Publishing Group.
  • Li, G., Duke, C., Roufogalis, B. (2002). The progress of Chinese medicine in Australia. In Kelvin Chan, Henry Lee (Eds.), the Way Forward for Chinese Medicine, (pp. 173-190). London & New York: BMJ Publishing Group.

Journals

  • Gupta, R., Chang, D., Nammi, S., Bensoussan, A., Bilinski, K., Roufogalis, B. (2017). Interactions between antidiabetic drugs and herbs: An overview of mechanisms of action and clinical implications. Diabetology & Metabolic Syndrome, 9(1), 1-12. [More Information]
  • Tan, A., Konczak, I., Li, G., Roufogalis, B., Sekhon, B., Sze, D. (2015). An ethnopharmacological approach to the preliminary screening of native Australian herbal medicines for anticancer activity. Journal of Complementary and Integrative Medicine, 12(3), 245-249. [More Information]
  • Roufogalis, B. (2015). Challenges in integrating herbal medicine in healthcare systems. Focus on Alternative and Complementary Therapies, 20(1), 34-35. [More Information]
  • Roufogalis, B., Nammi, S., Strehler, E. (2015). Natural Products: Biochemical-Chemical Characterization, and Evidence for Therapeutic Potential. Journal of Pharmacy and Pharmaceutical Sciences, 18(4), i-ii.
  • Roufogalis, B. (2014). Herbal extract lowers body-weight in overweight humans: Commentary. Focus on Alternative and Complementary Therapies, 19(2), 98-99. [More Information]
  • Song, M., Davis, N., Roufogalis, B., Huang, H. (2014). Management of Cardiorenal Metabolic Syndrome in Diabetes Mellitus: A Phytotherapeutic Perspective. Journal of Diabetes Research, 2014, 1-12. [More Information]
  • Li, Y., Tran, V., Kota, B., Nammi, S., Duke, C., Roufogalis, B. (2014). Preventative Effect of Zingiber officinale on Insulin Resistance in a High-Fat High-Carbohydrate Diet-Fed Rat Model and its Mechanism of Action. Basic and Clinical Pharmacology and Toxicology, 115(2), 209-215. [More Information]
  • Li, Y., Tran, V., Koolaji, N., Duke, C., Roufogalis, B. (2013). (S)-[6]-Gingerol enhances glucose uptake in L6 myotubes by activation of AMPK in response to [Ca2+]i. Journal of Pharmacy and Pharmaceutical Sciences, 16(2), 304-312. [More Information]
  • Kamato, D., Rezaei, H., Getachew, R., Thach, L., Guidone, D., Osman, N., Roufogalis, B., Duke, C., Tran, V., Zheng, W., et al (2013). (S)-[6]-Gingerol inhibits TGF-Beta-stimulated biglycan synthesis but not glycosaminoglycan hyperelongation in human vascular smooth muscle cells. Journal of Pharmacy and Pharmacology, 65(7), 1026-1036. [More Information]
  • Li, X., McGrath, K., Tran, V., Li, Y., Duke, C., Roufogalis, B., Heather, A. (2013). Attenuation of Proinflammatory Responses by S-[6]-Gingerol via Inhibition of ROS/NF-Kappa B/COX2 Activation in HuH7 Cells. Evidence-Based Complementary and Alternative Medicine, 2013, 1-8. [More Information]
  • Weiser, T., Roufogalis, B., Chrubasik, S. (2013). Comparison of the Effects of Pelargonic Acid Vanillylamide and Capsaicin on Human Vanilloid Receptors. Phytotherapy Research, 27(7), 1048-1053. [More Information]
  • Kim, M., Lee, K., Iseli, T., Hoy, A., George, J., Grewal, T., Roufogalis, B. (2013). Compound K modulates fatty acid-induced lipid droplet formation and expression of proteins involved in lipid metabolism in hepatocytes. Liver International, 33(10), 1583-1593. [More Information]
  • Kim, E., Chen, Y., Huang, J., Li, K., Razmovski-Naumovski, V., Poon, J., Chan, K., Roufogalis, B., McLachlan, A., Mo, S., Liu, Z., Li, G., et al (2013). Evidence-based toxicity evaluation and scheduling of Chinese herbal medicines. Journal of Ethnopharmacology, 146(1), 40-61. [More Information]
  • Li, X., McGrath, K., Tran, V., Li, Y., Mandadi, S., Duke, C., Heather, A., Roufogalis, B. (2013). Identification of a Calcium Signalling Pathway of S-[6]-Gingerol in HuH-7 Cells. Evidence-Based Complementary and Alternative Medicine, 2013, 1-7. [More Information]
  • Nammi, S., Roufogalis, B. (2013). Light-to-Moderate Ethanol Feeding Augments AMPK-alpha Phosphorylation and Attenuates SREBP-1 Expression in the Liver of Rats. Journal of Pharmacy and Pharmaceutical Sciences, 16(2), 342-351. [More Information]
  • Li, X., McGrath, K., Nammi, S., Heather, A., Roufogalis, B. (2012). Attenuation of Liver Pro-Inflammatory Responses by Zingiber officinale via Inhibition of NF-kappa B Activation in High-Fat Diet-Fed Rats. Basic and Clinical Pharmacology and Toxicology, 110(3), 238-244. [More Information]
  • Miller, K., Qing, C., Sze, D., Roufogalis, B., Neilan, B. (2012). Culturable Endophytes of Medicinal Plants and the Genetic Basis for Their Bioactivity. Microbial Ecology: an international journal, 64(2), 431-449. [More Information]
  • Kota, B., Abdul, M., Allen, J., Kalagara, M., Roufogalis, B. (2012). Effect of vitamin D3 supplementation on the pharmacokinetics of digoxin - a pilot study. Fundamental and Clinical Pharmacology, 26(4), 543-548. [More Information]
  • Dolton, M., Roufogalis, B., McLachlan, A. (2012). Fruit Juices as Perpetrators of Drug Interactions: The Role of Organic Anion-Transporting Polypeptides. Clinical Pharmacology & Therapeutics, 92(5), 622-630. [More Information]
  • Li, Y., Tran, V., Duke, C., Roufogalis, B. (2012). Gingerols of Zingiber officinale Enhance Glucose Uptake by Increasing Cell Surface GLUT4 in Cultured L6 Myotubes. Planta Medica: natural products and medicinal plant research, 78(14), 1549-1555. [More Information]
  • Huang, H., Roufogalis, B. (2012). Healing the Diabetic Heart: Modulation of Cardiometabolic Syndrome through Peroxisome Proliferator Activated Receptors (PPARs). Current Molecular Pharmacology, 5(2), 241-247. [More Information]
  • Brymora, A., Duggin, I., Berven, L., Van Dam, E., Roufogalis, B., Robinson, P. (2012). Identification and Characterisation of the RalA-ERp57 Interaction: Evidence for GDI Activity of ERp57. PloS One, 7(11), 1-11. [More Information]
  • Kim, M., Kung, S., Grewal, T., Roufogalis, B. (2012). Methodologies for investigating natural medicines for the treatment of nonalcoholic fatty liver disease (NAFLD). Current Pharmaceutical Biotechnology, 13(2), 278-291. [More Information]
  • Song, M., Roufogalis, B., Huang, H. (2012). Modulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-gamma-related pharmacology. British Journal of Pharmacology, 165(1), 4-19. [More Information]
  • Roufogalis, B., Grewal, T. (2012). New Methodology and Approaches to Intracellular Lipid Transport in Atherosclerosis and Cardiovascular Disease. Current Pharmaceutical Biotechnology, 13(2), 276-277. [More Information]
  • Li, Y., Tran, V., Duke, C., Roufogalis, B. (2012). Preventive and Protective Properties of Zingiber officinale (Ginger) in Diabetes Mellitus, Diabetic Complications, and Associated Lipid and Other Metabolic Disorders: A Brief Review. Evidence-Based Complementary and Alternative Medicine, 2012, 1-10. [More Information]
  • Song, M., Roufogalis, B., Huang, H. (2012). Reversal of the Caspase-Dependent Apoptotic Cytotoxicity Pathway by Taurine from Lycium barbarum (Goji Berry) in Human Retinal Pigment Epithelial Cells: Potential Benefit in Diabetic Retinopathy. Evidence - Based Complementary and Alternative Medicine, 2012, 1-11. [More Information]
  • Mo, S., Li, J., Loh, Y., Brown, R., Smith, A., Chen, Y., Joshua, D., Roufogalis, B., Li, G., Fan, K., Sze, D., et al (2011). Factors influencing the abundance of the side population in a human myeloma cell line. Bone Marrow Research, 2011, 524845-1-524845-8. [More Information]
  • Song, M., Salam, N., Roufogalis, B., Huang, H. (2011). Lycium barbarum (Goji Berry) extracts and its taurine component inhibit PPAR-y[gamma]-dependent gene transcription in human retinal pigment epithelial cells: Possible implications for diabetic retinopathy treatment. Biochemical Pharmacology, 82(9), 1209-1218. [More Information]
  • Tran, V., Marks, D., Duke, R., Bebawy, M., Duke, C., Roufogalis, B. (2011). Modulation of P-glycoprotein-Mediated Anticancer Drug Accumulation, Cytotoxicity, and ATPase Activity by Flavonoid Interactions. Nutrition and Cancer: an international journal, 63(3), 435-443. [More Information]
  • Mandadi, S., Armati, P., Roufogalis, B. (2011). Protein kinase C modulation of thermo-sensitive transient receptor potential channels: Implications for pain signaling. Journal of Natural Science, Biology and Medicine, 2(1), 13-25. [More Information]
  • Mandadi, S., Armati, P., Roufogalis, B. (2011). Real-Time Translocation and Function of PKCβII Isoform in Response to Nociceptive Signaling via the TRPV1 Pain Receptor. Pharmaceuticals, 4, 1503-1517. [More Information]
  • Kota, B., Allen, J., Roufogalis, B. (2011). The Effect of Vitamin D3 and Ketoconazole Combination on VDR-mediated P-gp Expression and Function in Human Colon Adenocarcinoma Cells: Implications in Drug Disposition and Resistance. Basic and Clinical Pharmacology and Toxicology, 109(2), 97-102. [More Information]
  • Kota, B., Tran, V., Allen, J., Bebawy, M., Roufogalis, B. (2010). Characterization of PXR mediated P-glycoprotein regulation in intestinal LS174T cells. Pharmacological Research, 62(5), 426-431. [More Information]
  • Miller, K., Ingrey, S., Alvin, A., Sze, D., Roufogalis, B., Neilan, B. (2010). Endophytes and the microbial genetics of traditional medicines. Microbiology Australia, 31(2), 60-63.
  • Omar, E., Kam, A., Alqahtani, A., Li, K., Razmovski-Naumovski, V., Nammi, S., Chan, K., Roufogalis, B., Li, G. (2010). Herbal Medicines and Nutraceuticals for Diabetic Vascular Complications: Mechanisms of Action and Bioactive Phytochemicals. Current Pharmaceutical Design, 16(34), 3776-3807. [More Information]
  • Razmovski-Naumovski, V., Tongkao-on, W., Kimble, B., Qiao, V., Lin, B., Li, K., Roufogalis, B., Depo, Y., Meicun, Y., Li, G. (2010). Multiple Chromatographic and Chemometric Methods for Quality Standardisation of Chinese Herbal Medicines. Modernization of Traditional Chinese Medicine, 12(1), 99-106. [More Information]
  • Mohammed Abdul, M., Jiang, X., Williams, K., Day, R., Roufogalis, B., Liauw, W., Xu, H., Matthias, A., Lehmann, R., McLachlan, A. (2010). Pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjects. British Journal of Clinical Pharmacology, 69(5), 508-515. [More Information]
  • Brown, J., Roufogalis, B., Williamson, M. (2009). Complementary Medicines: Hospital Pharmacists' Attitude, Knowledge and Information Seeking Behaviour. Journal of Pharmacy Practice and Research, 39(4), 281-285.
  • Nammi, S., Sreemantula, S., Roufogalis, B. (2009). Protective Effects of Ethanolic Extract of Zingiber officinale Rhizome on the Development of Metabolic Syndrome in High-Fat Diet-Fed Rats. Basic and Clinical Pharmacology and Toxicology, 104(5), 366-373. [More Information]
  • Nammi, S., Kim, M., Gavande, N., Li, G., Roufogalis, B. (2009). Regulation of Low-Density Lipoprotein Receptor and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Expression by Zingiber officinale in the Liver of High-Fat Diet-Fed Rats. Basic and Clinical Pharmacology and Toxicology, 106(5), 389-395. [More Information]
  • Huang, H., Teoh, A., Lin, B., Lin, D., Roufogalis, B. (2009). The role of herbal PPAR modulators in the treatment of cardiometabolic syndrome. Pharmacological Research, 60(3), 195-206. [More Information]
  • Chrubasik, C., Roufogalis, B., Muller-Ladner, U., Chrubasik, S. (2008). A Systematic Review on the Rosa canina Effect and Efficacy Profiles. Phytotherapy Research, 22(6), 725-733. [More Information]
  • Mohammed Abdul, M., Jiang, X., Williams, K., Day, R., Roufogalis, B., Liauw, W., Xu, H., McLachlan, A. (2008). Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. British Journal of Pharmacology, 154(8), 1691-1700. [More Information]
  • Li, Y., Qi, Y., Huang, H., Yamahara, J., Roufogalis, B. (2008). Pomegranate flower: a unique traditional antidiabetic medicine with dual PPAR-alpha/-gamma activator properties. Diabetes, Obesity and Metabolism, 10(1), 10-17. [More Information]
  • Loh, Y., Mo, S., Brown, R., Yamagishi, T., Yang, S., Joshua, D., Roufogalis, B., Sze, D. (2008). Presence of Hoechst low side populations in multiple myeloma. Leukemia and Lymphoma, 49(9), 1813-1816. [More Information]
  • Huang, H., He, L., Qin, Q., Yang, Q., Peng, G., Harada, M., Qi, Y., Yamahara, J., Roufogalis, B., Li, Y. (2008). Salacia oblonga root decreases cardiac hypertrophy in Zucker diabetic fatty rats: inhibition of cardiac expression of angiotensin II type 1 receptor. Diabetes, Obesity and Metabolism, 10(7), 574-585. [More Information]
  • Vlachojannis, J., Roufogalis, B., Chrubasik, S. (2008). Systematic Review on the Safety of Harpagophytum Preparations for Osteoarthritic and Low Back Pain. Phytotherapy Research, 22(2), 149-152. [More Information]
  • Mandadi, S., Roufogalis, B. (2008). ThermoTRP channels in nociceptors: Taking a lead from capsaicin receptor TRPV1. Current Neuropharmacology, 6(1), 21-38. [More Information]
  • Chrubasik, J., Roufogalis, B., Wagner, H., Chrubasik, S. (2007). A comprehensive review on nettle effect and efficacy profiles, part I: herba urticae. Phytomedicine, 14(6), 423-435. [More Information]
  • Chrubasik, J., Roufogalis, B., Wagner, H., Chrubasik, S. (2007). A comprehensive review on the stinging nettle effect and efficacy profiles. Part II: urticae radix. Phytomedicine, 14(7-8), 568-579. [More Information]
  • Fu, D., Roufogalis, B. (2007). Actin Disruption Inhibits Endosomal Traffic of P-glycoprotein-EGFP and Resistance to Daunorubicin Accumulation. American Journal of Physiology: Cell Physiology, 292(4), C1543-C1552. [More Information]
  • Loh, Y., Mo, S., Brown, R., Yamagishi, T., Yang, S., Joshua, D., Ho, P., Gibson, J., Roufogalis, B., Sze, D. (2007). Characteristics of 'side population' as the putative cancer stem cells in myeloma: Cell growth and differentiation capability. Molecular Cancer Therapeutics, 6(12), 3365s-3366s.
  • Chrubasik, J., Roufogalis, B., Chrubasik, S. (2007). Evidence of effectiveness of herbal antiinflammatory drugs in the treatment of painful osteoarthritis and chronic low back pain. Phytotherapy Research, 21(7), 675-683. [More Information]
  • Huang, H., Tran, V., Roufogalis, B., Li, Y. (2007). Gypenoside XLIX, a naturally occurring PPAR-α activator, inhibits cytokine-induced vascular cell adhesion molecule-1 expression and activity in human endothelial cells. European Journal of Pharmacology, 565(1-3), 158-165. [More Information]
  • Goh, P., Sze, D., Roufogalis, B. (2007). Molecular and cellular regulators of cancer angiogenesis. Current Cancer Drug Targets, 7(8), 743-758. [More Information]
  • Hesse, C., Razmovski-Naumovski, V., Duke, C., Davies, N., Roufogalis, B. (2007). Phytopreventative effects of Gynostemma pentaphyllum against acute indomethacin-induced gastrointestinal and renal toxicity in rats. Phytotherapy Research, 21(6), 523-530. [More Information]
  • Huang, H., Bebawy, M., Tran, V., Roufogalis, B. (2007). Specific reversal of multidrug resistance to colchicine in CEM/VLB(100) cells by Gynostemma pentaphyllum extract. Phytomedicine, 14(12), 830-839. [More Information]
  • Fu, D., van Dam, E., Brymora, A., Duggin, I., Robinson, P., Roufogalis, B. (2007). The small GTPases Rab5 and RalA regulate intracellular traffic of P-glycoprotein. Biochimica et Biophysica Acta, 1773 (7), 1062-1072. [More Information]
  • Riley, L., Roufogalis, B., Li, G., Weiss, A. (2006). A radioassay for synaptic core complex assembly: Screening of herbal extracts for effectors. Analytical Biochemistry, 357(1), 50-57. [More Information]
  • Tran, V., Kantharaj, R., Roufogalis, B., Duke, C. (2006). An Efficient and Facile Synthesis of Capsaicin-Like Compounds as Agonists of the TRPV1 Receptor. European Journal of Organic Chemistry, 2006 (13), 2970-2976. [More Information]
  • Megalli, S., Davies, N., Roufogalis, B. (2006). Anti-Hyperlipidemic and Hypoglycemic Effects of Gynostemma pentaphyllum in the Zucker Fatty Rat. Journal of Pharmacy and Pharmaceutical Sciences, 9(3), 281-291. [More Information]
  • Wen, S., Huang, H., Li, G., Yamahara, J., Roufogalis, B., Li, Y. (2006). Bromelain improves decrease in defecation in postoperative rats: Modulation of colonic gene expression of inducible nitric oxide synthase. Life Sciences, 78(9), 995-1002. [More Information]
  • Aktan, F., Henness, S., Tran, V., Duke, C., Roufogalis, B., Ammit, A. (2006). Gingerol Metabolite and a Synthetic Analogue Capsarol (TM) Inhibit Macrophage NF-kappaB Mediated iNOS Gene Expression and Enzyme Activity. Planta Medica: natural products and medicinal plant research, 72(8), 727-734. [More Information]
  • Huang, H., Li, Y., Razmovski-Naumovski, V., Tran, V., Li, G., Duke, C., Roufogalis, B. (2006). Gypenoside XLIX isolated from Gynostemma pentaphyllum inhibits nuclear factor-kappaB activation via a PPAR-alpha-dependent pathway. Journal of Biomedical Science, 13(4), 535-548. [More Information]
  • Huang, H., Tran, V., Roufogalis, B., Li, Y. (2006). Gypenoside XLIX, a naturally occurring gynosaponin, PPAR-alpha dependently inhibits LPS-induced tissue factor expression and activity in human THP-1 monocytic cells. Toxicology and Applied Pharmacology, 218(1), 30-36. [More Information]
  • Huang, H., Tran, V., Duke, R., Tan, S., Chrubasik, S., Roufogalis, B., Duke, C. (2006). Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-kB activation. Journal of Ethnopharmacology, 104(1-2), 149-155. [More Information]
  • Qi, J., Wang, J., Mandadi, S., Tanaka, K., Roufogalis, B., Madigan, M., Lai, K., Yan, F., Chong, B., Stevens, R., et al (2006). Human and mouse mast cells use the tetraspanin CD9 as an alternate interleukin-16 receptor. Blood, 107(1), 135-142. [More Information]
  • Mandadi, S., Tominaga, T., Numazaki, M., Murayama, N., Saito, N., Armati, P., Roufogalis, B., Tominaga, M. (2006). Increased sensitivity of desensitized TRPV1 by PMA occurs through PKCe-mediated phosphorylation at S800. Pain, 123(1-2), 106-116. [More Information]
  • Huang, H., Yang, Q., Harada, M., Uberai, J., Radford, J., Li, G., Yamahara, J., Roufogalis, B., Li, Y. (2006). Salacia oblonga root improves cardiac lipid metabolism in Zucker diabetic fatty rats: Modulation of cardiac PPAR-a-mediated transcription of fatty acid metabolic genes. Toxicology and Applied Pharmacology, 210(1-2), 78-85. [More Information]
  • Huang, H., Peng, G., Li, G., Yamahara, J., Roufogalis, B., Li, Y. (2006). Salacia oblonga root improves postprandial hyperlipidemia and hepatic steatosis in Zucker diabetic fatty rats: activation of PPAR-alpha. Toxicology and Applied Pharmacology, 210(3), 225-235. [More Information]
  • Holland, M., Panetta, J., Hoskins, J., Bebawy, M., Roufogalis, B., Allen, J., Arnold, J. (2006). The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells. Biochemical Pharmacology, 71(8), 1146-1154. [More Information]
  • Huang, H., Razmovski-Naumovski, V., Salam, N., Duke, R., Tran, V., Duke, C., Roufogalis, B. (2005). A novel LXR-a activator identified from the natural product Gynostemma pentaphyllum. Biochemical Pharmacology, 70(9), 1298-1308. [More Information]
  • Kota, B., Huang, H., Roufogalis, B. (2005). An overview on biological mechanisms of PPARs. Pharmacological Research, 51(2), 85-94. [More Information]
  • Huang, H., Peng, G., Kota, B., Li, G., Yamahara, J., Roufogalis, B., Li, Y. (2005). Anti-diabetic action of Punica granatum flower extract: activation of PPAR and identification of an active component. Toxicology and Applied Pharmacology, 207(2), 160-169. [More Information]
  • Razmovski-Naumovski, V., Huang, H., Tran, V., Li, G., Duke, C., Roufogalis, B. (2005). Chemistry and pharmacology of Gynostemma pentaphyllum. Phytochemistry Reviews, 4(3-Feb), 197-219. [More Information]
  • Jiang, X., Williams, K., Liauw, W., Ammit, A., Roufogalis, B., Duke, C., Day, R., McLachlan, A. (2005). Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. British Journal of Clinical Pharmacology, 59(4), 425-432. [More Information]
  • Huang, H., Kota, B., Razmovski-Naumovsk, V., Roufogalis, B. (2005). Herbal or Natural Medicines as Modulators of Peroxisome Proliferated-Activated Receptors and Related Nuclear Receptors for Therapy of Metabolic Syndrome. Basic and Clinical Pharmacology and Toxicology, 96(1), 3-14. [More Information]
  • Megalli, S., Aktan, F., Davies, N., Roufogalis, B. (2005). Phytopreventative anti-hyperlipidemic effects of gynostemma pentaphyllum in rats. Journal of Pharmacy and Pharmaceutical Sciences, 8(3), 507-515. [More Information]
  • Huang, H., Yang, Q., Harada, M., Li, G., Yamahara, J., Roufogalis, B., Li, Y. (2005). Pomegranate Flower Extract Diminishes Cardiac Fibrosis in Zucker Diabetic Fatty Rats: Modulation of Cardiac Endothelin-1 and Nuclear Factor-kappaB Pathways. Journal of Cardiovascular Pharmacology, 46(6), 856-862. [More Information]
  • Huang, H., Peng, G., Kota, B., Li, G., Yamahara, J., Roufogalis, B., Li, Y. (2005). Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids. British Journal of Pharmacology, 145(6), 767-774. [More Information]
  • Li, Y., Wen, S., Kota, B., Peng, G., Li, G., Yamahara, J., Roufogalis, B. (2005). Punica granatum flower extract, a potent a-glucosidase inhibitor, improves postprandial hyperglycemia in Zucker diabetic fatty rats. Journal of Ethnopharmacology, 99(2), 239-244. [More Information]
  • Huang, H., Razmovski-Naumovski, V., Kota, B., Lin, D., Roufogalis, B. (2005). The pathophysiological function of peroxisome proliferator-activated receptor-gamma in lung-related diseases. Respiratory Research, 6(1), 102-1-102-9. [More Information]
  • Chrubasik, S., Pittler, M., Roufogalis, B. (2005). Zingiberis rhizoma: A comprehensive review on the ginger effect and efficacy profiles. Phytomedicine, 12(9), 684-701. [More Information]
  • Mandadi, S., Numazaki, M., Tominaga, M., Bhat, M., Armati, P., Roufogalis, B. (2004). Activation Of Protein Kinase C Reverses Capsaicin-Induced Calcium-Dependent Desensitization Of Trpv1 Ion Channels. Cell Calcium, 35(5), 471-478. [More Information]
  • Fu, D., Bebawy, M., Kable, E., Roufogalis, B. (2004). Dynamic And Intracellular Trafficking Of P-Glycoprotein-EGFP Fusion Protein: Implications In Multidrug Resistance In Cancer. International Journal of Cancer, 109(2), 174-181. [More Information]
  • Pajic, M., Bebawy, M., Hoskins, J., Roufogalis, B., Rivory, L. (2004). Effect Of Short-Term Morphine Exposure On P-Glycoprotein Expression And Activity In Cancer Cell Lines. Oncology Reports, 11(5), 1091-1095.
  • Jiang, X., Williams, K., Liauw, W., Ammit, A., Roufogalis, B., Duke, C., Day, R., McLachlan, A. (2004). Effect Of St John's Wort And Ginseng On The Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects. British Journal of Clinical Pharmacology, 57(5), 592-599. [More Information]
  • Chrubasik, S., Conradt, C., Roufogalis, B. (2004). Effectiveness of Harpagophytum extracts and clinical efficacy. Phytotherapy Research, 18(2), 187-189. [More Information]
  • Coxeter, P., McLachlan, A., Duke, C., Roufogalis, B. (2004). Herb-Drug Interactions: An Evidence Based Approach. Current Medicinal Chemistry, 11(11), 1513-1525.
  • Li, Y., Peng, G., Li, G., Wen, S., Huang, H., Roufogalis, B., Yamahara, J. (2004). Salacia Oblonga Improves Cardiac Fibrosis And Inhibits Postprandial Hyperglycemia In Obese Zucker Rats. Life Sciences, 75(14), 1735-1746. [More Information]
  • Huang, H., Kota, P., Li, Y., Goh, P., Roufogalis, B. (2003). Ayurveda: tapping into India's rich anti-diabetic pharmacopoeia. Pharmacy News, , 9-10.
  • Wanigasekara-Mohotti, Y., Armati, P., Roufogalis, B. (2003). Ca2+-ATPase isoforms are expressed in neuroprotection in rat, but not human, neurons. NeuroReport, 14(18), 2421-2424.
  • Nurtjahja-Tjendraputra, E., Ammit, A., Roufogalis, B., Tran, V., Duke, C. (2003). Effective anti-platelet and cox-1 enzyme inhibitors from pungent constituents of ginger. Thrombosis Research, 111, 259-265. [More Information]
  • Coxeter, P., McLachlan, A., Duke, C., Roufogalis, B. (2003). Garlic-drug interactions. The Journal of Complementary Medicine, 11, 57-59.
  • Coxeter, P., McLachlan, A., Duke, C., Roufogalis, B. (2003). Ginkgo biloba interactions. The Journal of Complementary Medicine, 11, 70-72.
  • Aktan, F., Henness, S., Roufogalis, B., Ammit, A. (2003). Gypenosides derived from gynostemma pentaphyllum suppress no synthesis in murine macrophages by inhibiting inos enzymatic activity and attenuating nf-kb-mediated inos protein expression. Nitric Oxide: Biology And Chemistry, 8(4), 235-242. [More Information]
  • Coxeter, P., McLachlan, A., Duke, C., Roufogalis, B. (2003). Interaction or over-reaction? Journal of Alternative and Complementary Medicine, 11, 60-61.
  • Coxeter, P., McLachlan, A., Duke, C., Roufogalis, B. (2003). Liquorice-drug interactions. The Journal of Complementary Medicine, 11, 40-43.
  • Coxeter, P., McLachlan, A., Duke, C., Roufogalis, B. (2003). St John's wort interactions. Journal of Alternative and Complementary Medicine, 11, 66-68.
  • Li, G., Duke, C., Roufogalis, B. (2003). The quality and safety of traditional Chinese medicines. Australian Prescriber, 26(6), 128-130.
  • Dedov, V., Tran, V., Duke, C., Connor, M., Christie, M., Mandadi, S., Roufogalis, B. (2002). Gingerols: a novel class of vanilloid receptor (VR1) agonists. British Journal of Pharmacology, 137(6), 793-798. [More Information]
  • Duke, R., Chebib, M., Duke, C., Johnston, G., Roufogalis, B. (2002). Ginkgo biloba - food for the brain. New Zealand Pharmacy, , 27-33.
  • Qi, J., Stevens, R., Wadley, R., Collins, A., Cooley, M., Naif, H., Nasr, N., Cunningham, A., Katsoulotos, G., Wanigasekara-Mohotti, Y., Roufogalis, B., et al (2002). IL-16 Regulation of Human Mast Cells/Basophils and Their Susceptability to HIV-1. Journal of Immunology, 168(8), 4127-4134.
  • Li, G., Duke, C., Roufogalis, B. (2001). A new approach to advanced educaiton in herbal medicines established at the University of Sydney. Australian Journal of Chinese Medicine, , 82-84.
  • Tjendraputra, E., Tran, V., Liu-Brennan, D., Roufogalis, B., Duke, C. (2001). Effect of Ginger Constituents and Synthetic Analogues on Cyclooxygenase-2 Enzyme in Intact Cells. Bioorganic Chemistry, 29(3), 156-163.
  • Tjendraputra, E., Tran, V., Liu-Brennan, D., Roufogalis, B., Duke, C. (2001). Effects of ginger constituents and synthetic analogues on cyclooxygenase-2 enzyme in intact cells. Bioorganic Chemistry, 29(3), 156-163.
  • Brymora, A., Cousin,, M., Roufogalis, B., Robinson, P. (2001). Enhanced Protein Recovery and Reproducibility from Pull-Down Assays and Immunoprecipitations using spin columns. Analytical Biochemistry, 295(1), 119-122.
  • Goh, P., Roufogalis, B. (2001). Feverfew for migrain prophylaxis. Australian Pharmacy Trade, 37224, 1-2.
  • Koo, K., Ammit, A., Tran, V., Duke, C., Roufogalis, B. (2001). Gingerols and related analogues inhibit arachidonic acid-induced human platelet serotonin release and aggregation. Thrombosis Research, 103, 387-397.
  • Goh, P., Roufogalis, B. (2001). Horse chestnut seed extract for CVI. Australian Pharmacy Trade, 37210, 16-17.
  • Chrubasik, S., Roufogalis, B. (2001). Issues in quality and comparability of herbal medicinal products - part 1. Australian Journal of Pharmacy, 82, May, 444-445.
  • Chrubasik, S., Roufogalis, B. (2001). Issues in quality and comparability of herbal medicinal products - part 2. Australian Journal of Pharmacy, 82, June, 546-548.
  • Chrubasik, S., Roufogalis, B. (2001). Milk thistle fruit for liver diseases. Australian Pharmacy Trade, 37236, 1-2.
  • Chrubasik, S., Roufogalis, B. (2001). Pain relief with herbal antirheumatics. New Zealand Pharmacy, June, 19-24.
  • Bebawy, M., Morris, M., Roufogalis, B. (2001). Selective modulation of P-glycoprotein-mediated drug resistance. British Journal of Cancer, 85(12), 1998-2003.
  • Brymora, A., Roufogalis, B., Robinson, P., Valova, V., Larsen, M. (2001). The brain exocyst complex interacts with RalA in a GTP-dependent manner - Identification of a novel mammalian Sec3 gene and a second Sec15 gene. Journal of Biological Chemistry, 276(32), 29792-29797.
  • Dedov, V., Cox, G., Roufogalis, B. (2001). Visualisation of mitochondria in living neurons with sing;e and two-photon fluorescence laser microscopy. Micron, 32, 653-660. [More Information]
  • Dedov, V., Cox, G., Roufogalis, B. (2001). Visualization of mitochondria in living neurons with single- and two-photon fluorescence laser microscopy. Micron, 32(7), 653-660. [More Information]

Conferences

  • Holland, M., Allen, J., Bebawy, M., Roufogalis, B., Arnold, J. (2005). Cannabinoid Modulation of P-Glycoprtein Efflux Activity and Expression (Netherlands). Interantional association for cannabis as medicine conference, The Netherlands: Australian Society of Clinical and experimental Pharmacologists and Toxicologista.
  • Arnold, J., Holland, M., Bebawy, M., Roufogalis, B., Allen, J. (2005). Cannabinoid Modulation of P-Glycoprtein Efflux Activity and Expression (Spain). SOCIEDAD ESPANOLA DE INVESTIGACION SOBRE CANNABINOIDES, Barcelona: Australian Society of Clinical and experimental Pharmacologists and Toxicologista.
  • Fu, D., Roufogalis, B. (2004). Endosomal trafficking of P-Glycoprotein: actin dependence. ABC Transporters Symposium, Sydney.
  • Fu, D., Roufogalis, B. (2003). Cellular localization of P-gp-EGFP correlates with cytotoxic drug accumulation in cancer cells. Hunter Cellular Biology Meeting, Australia: Cellular Biology Meeting Inc,.
  • Fu, D., Roufogalis, B. (2003). Intracellular trafficking and recycling of P-glycoprotein-EGFP fusion is actin dependent. 43rd Annual Meeting of the American Society for Cell Biology, USA: American Society for Cell Biology.
  • Fu, D., Roufogalis, B. (2003). Overcoming multidrug resistance by blocking intracellular trafficking of P-glycoprotein in human cancer cells. APSA (Australia Pharmaceutical Science Association) 2003 Conference, Integrating Research into Practice, Australia: Australia Pharmaceutical Science Association.
  • Li, G., Duke, C., Roufogalis, B. (2002). An integrative east-west herbal medicine education model in Sydney. First International Symposium on TCM Education.
  • Fu, D., Bebawy, M., Kable, E., Roufogalis, B. (2002). Characterisation and intracellular localisation of P-glycoprotein-EGFP fusion protein. ComBio 2002, Sydney: Australian Society for Biochemistry and Molecular Biology.
  • Roufogalis, B., Dedov, V., Tran, V., Duke, C. (2002). Development of gingerols and synthetic derivatives for pain and inflammation. 5th Australia/Japan Symposium on Drug Design and Development.
  • Mandadi, S., Armati, P., Roufogalis, B. (2002). Specific translocation of protein kinase cisoforms in rat dorsal root gnaglion neurons and activation of VR-1 polymodal receptors. 10th World Congress on Pain, USA: International Association for the Study of Pain Press.
  • Li, G., Duke, C., Roufogalis, B. (2001). Innovative approach to education of hebal medicine. Ed-Health, : World Scientific Publishing.

Patents

  • Roufogalis, B., Duke, C., Tran, V. (2010). Medicinal Uses Of Phenylalkanols And Derivatives (Gingerol Analogues). Patent No. 2307028. Canada.
  • Roufogalis, B., Duke, C., Tran, V. (2006). Medicinal Uses Of Phenylalkanols And Derivatives. Patent No. 1056700.

2017

  • Gupta, R., Chang, D., Nammi, S., Bensoussan, A., Bilinski, K., Roufogalis, B. (2017). Interactions between antidiabetic drugs and herbs: An overview of mechanisms of action and clinical implications. Diabetology & Metabolic Syndrome, 9(1), 1-12. [More Information]

2015

  • Tan, A., Konczak, I., Li, G., Roufogalis, B., Sekhon, B., Sze, D. (2015). An ethnopharmacological approach to the preliminary screening of native Australian herbal medicines for anticancer activity. Journal of Complementary and Integrative Medicine, 12(3), 245-249. [More Information]
  • Roufogalis, B. (2015). Challenges in integrating herbal medicine in healthcare systems. Focus on Alternative and Complementary Therapies, 20(1), 34-35. [More Information]
  • Roufogalis, B., Nammi, S., Strehler, E. (2015). Natural Products: Biochemical-Chemical Characterization, and Evidence for Therapeutic Potential. Journal of Pharmacy and Pharmaceutical Sciences, 18(4), i-ii.

2014

  • Roufogalis, B. (2014). Herbal extract lowers body-weight in overweight humans: Commentary. Focus on Alternative and Complementary Therapies, 19(2), 98-99. [More Information]
  • Song, M., Davis, N., Roufogalis, B., Huang, H. (2014). Management of Cardiorenal Metabolic Syndrome in Diabetes Mellitus: A Phytotherapeutic Perspective. Journal of Diabetes Research, 2014, 1-12. [More Information]
  • Li, Y., Tran, V., Kota, B., Nammi, S., Duke, C., Roufogalis, B. (2014). Preventative Effect of Zingiber officinale on Insulin Resistance in a High-Fat High-Carbohydrate Diet-Fed Rat Model and its Mechanism of Action. Basic and Clinical Pharmacology and Toxicology, 115(2), 209-215. [More Information]

2013

  • Li, Y., Tran, V., Koolaji, N., Duke, C., Roufogalis, B. (2013). (S)-[6]-Gingerol enhances glucose uptake in L6 myotubes by activation of AMPK in response to [Ca2+]i. Journal of Pharmacy and Pharmaceutical Sciences, 16(2), 304-312. [More Information]
  • Kamato, D., Rezaei, H., Getachew, R., Thach, L., Guidone, D., Osman, N., Roufogalis, B., Duke, C., Tran, V., Zheng, W., et al (2013). (S)-[6]-Gingerol inhibits TGF-Beta-stimulated biglycan synthesis but not glycosaminoglycan hyperelongation in human vascular smooth muscle cells. Journal of Pharmacy and Pharmacology, 65(7), 1026-1036. [More Information]
  • Li, X., McGrath, K., Tran, V., Li, Y., Duke, C., Roufogalis, B., Heather, A. (2013). Attenuation of Proinflammatory Responses by S-[6]-Gingerol via Inhibition of ROS/NF-Kappa B/COX2 Activation in HuH7 Cells. Evidence-Based Complementary and Alternative Medicine, 2013, 1-8. [More Information]
  • Weiser, T., Roufogalis, B., Chrubasik, S. (2013). Comparison of the Effects of Pelargonic Acid Vanillylamide and Capsaicin on Human Vanilloid Receptors. Phytotherapy Research, 27(7), 1048-1053. [More Information]
  • Kim, M., Lee, K., Iseli, T., Hoy, A., George, J., Grewal, T., Roufogalis, B. (2013). Compound K modulates fatty acid-induced lipid droplet formation and expression of proteins involved in lipid metabolism in hepatocytes. Liver International, 33(10), 1583-1593. [More Information]
  • Kim, E., Chen, Y., Huang, J., Li, K., Razmovski-Naumovski, V., Poon, J., Chan, K., Roufogalis, B., McLachlan, A., Mo, S., Liu, Z., Li, G., et al (2013). Evidence-based toxicity evaluation and scheduling of Chinese herbal medicines. Journal of Ethnopharmacology, 146(1), 40-61. [More Information]
  • Li, X., McGrath, K., Tran, V., Li, Y., Mandadi, S., Duke, C., Heather, A., Roufogalis, B. (2013). Identification of a Calcium Signalling Pathway of S-[6]-Gingerol in HuH-7 Cells. Evidence-Based Complementary and Alternative Medicine, 2013, 1-7. [More Information]
  • Nammi, S., Roufogalis, B. (2013). Light-to-Moderate Ethanol Feeding Augments AMPK-alpha Phosphorylation and Attenuates SREBP-1 Expression in the Liver of Rats. Journal of Pharmacy and Pharmaceutical Sciences, 16(2), 342-351. [More Information]

2012

  • Li, X., McGrath, K., Nammi, S., Heather, A., Roufogalis, B. (2012). Attenuation of Liver Pro-Inflammatory Responses by Zingiber officinale via Inhibition of NF-kappa B Activation in High-Fat Diet-Fed Rats. Basic and Clinical Pharmacology and Toxicology, 110(3), 238-244. [More Information]
  • Miller, K., Qing, C., Sze, D., Roufogalis, B., Neilan, B. (2012). Culturable Endophytes of Medicinal Plants and the Genetic Basis for Their Bioactivity. Microbial Ecology: an international journal, 64(2), 431-449. [More Information]
  • Kota, B., Abdul, M., Allen, J., Kalagara, M., Roufogalis, B. (2012). Effect of vitamin D3 supplementation on the pharmacokinetics of digoxin - a pilot study. Fundamental and Clinical Pharmacology, 26(4), 543-548. [More Information]
  • Dolton, M., Roufogalis, B., McLachlan, A. (2012). Fruit Juices as Perpetrators of Drug Interactions: The Role of Organic Anion-Transporting Polypeptides. Clinical Pharmacology & Therapeutics, 92(5), 622-630. [More Information]
  • Li, Y., Tran, V., Duke, C., Roufogalis, B. (2012). Gingerols of Zingiber officinale Enhance Glucose Uptake by Increasing Cell Surface GLUT4 in Cultured L6 Myotubes. Planta Medica: natural products and medicinal plant research, 78(14), 1549-1555. [More Information]
  • Huang, H., Roufogalis, B. (2012). Healing the Diabetic Heart: Modulation of Cardiometabolic Syndrome through Peroxisome Proliferator Activated Receptors (PPARs). Current Molecular Pharmacology, 5(2), 241-247. [More Information]
  • Brymora, A., Duggin, I., Berven, L., Van Dam, E., Roufogalis, B., Robinson, P. (2012). Identification and Characterisation of the RalA-ERp57 Interaction: Evidence for GDI Activity of ERp57. PloS One, 7(11), 1-11. [More Information]
  • Kim, M., Kung, S., Grewal, T., Roufogalis, B. (2012). Methodologies for investigating natural medicines for the treatment of nonalcoholic fatty liver disease (NAFLD). Current Pharmaceutical Biotechnology, 13(2), 278-291. [More Information]
  • Song, M., Roufogalis, B., Huang, H. (2012). Modulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-gamma-related pharmacology. British Journal of Pharmacology, 165(1), 4-19. [More Information]
  • Roufogalis, B., Grewal, T. (2012). New Methodology and Approaches to Intracellular Lipid Transport in Atherosclerosis and Cardiovascular Disease. Current Pharmaceutical Biotechnology, 13(2), 276-277. [More Information]
  • Kota, B., Wei Teoh, A., Roufogalis, B. (2012). Pharmacology of Traditional Herbal Medicines and Their Active Principles Used in the Treatment of Peptic Ulcer, Diarrhoea and Inflammatory Bowel Disease. In Thomas Brzozowski (Eds.), New Advances in the Basic and Clinical Gastroenterology, (pp. 297-310). Croatia: InTech Publishers. [More Information]
  • Li, Y., Tran, V., Duke, C., Roufogalis, B. (2012). Preventive and Protective Properties of Zingiber officinale (Ginger) in Diabetes Mellitus, Diabetic Complications, and Associated Lipid and Other Metabolic Disorders: A Brief Review. Evidence-Based Complementary and Alternative Medicine, 2012, 1-10. [More Information]
  • Song, M., Roufogalis, B., Huang, H. (2012). Reversal of the Caspase-Dependent Apoptotic Cytotoxicity Pathway by Taurine from Lycium barbarum (Goji Berry) in Human Retinal Pigment Epithelial Cells: Potential Benefit in Diabetic Retinopathy. Evidence - Based Complementary and Alternative Medicine, 2012, 1-11. [More Information]

2011

  • Mo, S., Li, J., Loh, Y., Brown, R., Smith, A., Chen, Y., Joshua, D., Roufogalis, B., Li, G., Fan, K., Sze, D., et al (2011). Factors influencing the abundance of the side population in a human myeloma cell line. Bone Marrow Research, 2011, 524845-1-524845-8. [More Information]
  • Song, M., Salam, N., Roufogalis, B., Huang, H. (2011). Lycium barbarum (Goji Berry) extracts and its taurine component inhibit PPAR-y[gamma]-dependent gene transcription in human retinal pigment epithelial cells: Possible implications for diabetic retinopathy treatment. Biochemical Pharmacology, 82(9), 1209-1218. [More Information]
  • Tran, V., Marks, D., Duke, R., Bebawy, M., Duke, C., Roufogalis, B. (2011). Modulation of P-glycoprotein-Mediated Anticancer Drug Accumulation, Cytotoxicity, and ATPase Activity by Flavonoid Interactions. Nutrition and Cancer: an international journal, 63(3), 435-443. [More Information]
  • Mandadi, S., Armati, P., Roufogalis, B. (2011). Protein kinase C modulation of thermo-sensitive transient receptor potential channels: Implications for pain signaling. Journal of Natural Science, Biology and Medicine, 2(1), 13-25. [More Information]
  • Mandadi, S., Armati, P., Roufogalis, B. (2011). Real-Time Translocation and Function of PKCβII Isoform in Response to Nociceptive Signaling via the TRPV1 Pain Receptor. Pharmaceuticals, 4, 1503-1517. [More Information]
  • Kota, B., Allen, J., Roufogalis, B. (2011). The Effect of Vitamin D3 and Ketoconazole Combination on VDR-mediated P-gp Expression and Function in Human Colon Adenocarcinoma Cells: Implications in Drug Disposition and Resistance. Basic and Clinical Pharmacology and Toxicology, 109(2), 97-102. [More Information]

2010

  • Kota, B., Tran, V., Allen, J., Bebawy, M., Roufogalis, B. (2010). Characterization of PXR mediated P-glycoprotein regulation in intestinal LS174T cells. Pharmacological Research, 62(5), 426-431. [More Information]
  • Miller, K., Ingrey, S., Alvin, A., Sze, D., Roufogalis, B., Neilan, B. (2010). Endophytes and the microbial genetics of traditional medicines. Microbiology Australia, 31(2), 60-63.
  • Omar, E., Kam, A., Alqahtani, A., Li, K., Razmovski-Naumovski, V., Nammi, S., Chan, K., Roufogalis, B., Li, G. (2010). Herbal Medicines and Nutraceuticals for Diabetic Vascular Complications: Mechanisms of Action and Bioactive Phytochemicals. Current Pharmaceutical Design, 16(34), 3776-3807. [More Information]
  • Roufogalis, B., Duke, C., Tran, V. (2010). Medicinal Uses Of Phenylalkanols And Derivatives (Gingerol Analogues). Patent No. 2307028. Canada.
  • Razmovski-Naumovski, V., Tongkao-on, W., Kimble, B., Qiao, V., Lin, B., Li, K., Roufogalis, B., Depo, Y., Meicun, Y., Li, G. (2010). Multiple Chromatographic and Chemometric Methods for Quality Standardisation of Chinese Herbal Medicines. Modernization of Traditional Chinese Medicine, 12(1), 99-106. [More Information]
  • Mohammed Abdul, M., Jiang, X., Williams, K., Day, R., Roufogalis, B., Liauw, W., Xu, H., Matthias, A., Lehmann, R., McLachlan, A. (2010). Pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjects. British Journal of Clinical Pharmacology, 69(5), 508-515. [More Information]

2009

  • Brown, J., Roufogalis, B., Williamson, M. (2009). Complementary Medicines: Hospital Pharmacists' Attitude, Knowledge and Information Seeking Behaviour. Journal of Pharmacy Practice and Research, 39(4), 281-285.
  • Nammi, S., Sreemantula, S., Roufogalis, B. (2009). Protective Effects of Ethanolic Extract of Zingiber officinale Rhizome on the Development of Metabolic Syndrome in High-Fat Diet-Fed Rats. Basic and Clinical Pharmacology and Toxicology, 104(5), 366-373. [More Information]
  • Nammi, S., Kim, M., Gavande, N., Li, G., Roufogalis, B. (2009). Regulation of Low-Density Lipoprotein Receptor and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Expression by Zingiber officinale in the Liver of High-Fat Diet-Fed Rats. Basic and Clinical Pharmacology and Toxicology, 106(5), 389-395. [More Information]
  • Huang, H., Teoh, A., Lin, B., Lin, D., Roufogalis, B. (2009). The role of herbal PPAR modulators in the treatment of cardiometabolic syndrome. Pharmacological Research, 60(3), 195-206. [More Information]

2008

  • Chrubasik, C., Roufogalis, B., Muller-Ladner, U., Chrubasik, S. (2008). A Systematic Review on the Rosa canina Effect and Efficacy Profiles. Phytotherapy Research, 22(6), 725-733. [More Information]
  • Razmovski-Naumovski, V., Duke, R., Tran, V., Li, G., Tattam, B., Roufogalis, B., Duke, C. (2008). Current methods in the isolation and characterisation of saponins from Gynostemma pentaphyllum. In Francesco Epifano (Eds.), Current Trends in Phytochemistry, (pp. 283-309). Kerala, India: Research Signpost.
  • Mohammed Abdul, M., Jiang, X., Williams, K., Day, R., Roufogalis, B., Liauw, W., Xu, H., McLachlan, A. (2008). Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. British Journal of Pharmacology, 154(8), 1691-1700. [More Information]
  • Li, Y., Qi, Y., Huang, H., Yamahara, J., Roufogalis, B. (2008). Pomegranate flower: a unique traditional antidiabetic medicine with dual PPAR-alpha/-gamma activator properties. Diabetes, Obesity and Metabolism, 10(1), 10-17. [More Information]
  • Loh, Y., Mo, S., Brown, R., Yamagishi, T., Yang, S., Joshua, D., Roufogalis, B., Sze, D. (2008). Presence of Hoechst low side populations in multiple myeloma. Leukemia and Lymphoma, 49(9), 1813-1816. [More Information]
  • Huang, H., He, L., Qin, Q., Yang, Q., Peng, G., Harada, M., Qi, Y., Yamahara, J., Roufogalis, B., Li, Y. (2008). Salacia oblonga root decreases cardiac hypertrophy in Zucker diabetic fatty rats: inhibition of cardiac expression of angiotensin II type 1 receptor. Diabetes, Obesity and Metabolism, 10(7), 574-585. [More Information]
  • Vlachojannis, J., Roufogalis, B., Chrubasik, S. (2008). Systematic Review on the Safety of Harpagophytum Preparations for Osteoarthritic and Low Back Pain. Phytotherapy Research, 22(2), 149-152. [More Information]
  • Mandadi, S., Roufogalis, B. (2008). ThermoTRP channels in nociceptors: Taking a lead from capsaicin receptor TRPV1. Current Neuropharmacology, 6(1), 21-38. [More Information]

2007

  • Chrubasik, J., Roufogalis, B., Wagner, H., Chrubasik, S. (2007). A comprehensive review on nettle effect and efficacy profiles, part I: herba urticae. Phytomedicine, 14(6), 423-435. [More Information]
  • Chrubasik, J., Roufogalis, B., Wagner, H., Chrubasik, S. (2007). A comprehensive review on the stinging nettle effect and efficacy profiles. Part II: urticae radix. Phytomedicine, 14(7-8), 568-579. [More Information]
  • Fu, D., Roufogalis, B. (2007). Actin Disruption Inhibits Endosomal Traffic of P-glycoprotein-EGFP and Resistance to Daunorubicin Accumulation. American Journal of Physiology: Cell Physiology, 292(4), C1543-C1552. [More Information]
  • Loh, Y., Mo, S., Brown, R., Yamagishi, T., Yang, S., Joshua, D., Ho, P., Gibson, J., Roufogalis, B., Sze, D. (2007). Characteristics of 'side population' as the putative cancer stem cells in myeloma: Cell growth and differentiation capability. Molecular Cancer Therapeutics, 6(12), 3365s-3366s.
  • Chrubasik, J., Roufogalis, B., Chrubasik, S. (2007). Evidence of effectiveness of herbal antiinflammatory drugs in the treatment of painful osteoarthritis and chronic low back pain. Phytotherapy Research, 21(7), 675-683. [More Information]
  • Huang, H., Tran, V., Roufogalis, B., Li, Y. (2007). Gypenoside XLIX, a naturally occurring PPAR-α activator, inhibits cytokine-induced vascular cell adhesion molecule-1 expression and activity in human endothelial cells. European Journal of Pharmacology, 565(1-3), 158-165. [More Information]
  • Goh, P., Sze, D., Roufogalis, B. (2007). Molecular and cellular regulators of cancer angiogenesis. Current Cancer Drug Targets, 7(8), 743-758. [More Information]
  • Hesse, C., Razmovski-Naumovski, V., Duke, C., Davies, N., Roufogalis, B. (2007). Phytopreventative effects of Gynostemma pentaphyllum against acute indomethacin-induced gastrointestinal and renal toxicity in rats. Phytotherapy Research, 21(6), 523-530. [More Information]
  • Huang, H., Bebawy, M., Tran, V., Roufogalis, B. (2007). Specific reversal of multidrug resistance to colchicine in CEM/VLB(100) cells by Gynostemma pentaphyllum extract. Phytomedicine, 14(12), 830-839. [More Information]
  • Fu, D., van Dam, E., Brymora, A., Duggin, I., Robinson, P., Roufogalis, B. (2007). The small GTPases Rab5 and RalA regulate intracellular traffic of P-glycoprotein. Biochimica et Biophysica Acta, 1773 (7), 1062-1072. [More Information]

2006

  • Riley, L., Roufogalis, B., Li, G., Weiss, A. (2006). A radioassay for synaptic core complex assembly: Screening of herbal extracts for effectors. Analytical Biochemistry, 357(1), 50-57. [More Information]
  • Tran, V., Kantharaj, R., Roufogalis, B., Duke, C. (2006). An Efficient and Facile Synthesis of Capsaicin-Like Compounds as Agonists of the TRPV1 Receptor. European Journal of Organic Chemistry, 2006 (13), 2970-2976. [More Information]
  • Megalli, S., Davies, N., Roufogalis, B. (2006). Anti-Hyperlipidemic and Hypoglycemic Effects of Gynostemma pentaphyllum in the Zucker Fatty Rat. Journal of Pharmacy and Pharmaceutical Sciences, 9(3), 281-291. [More Information]
  • Wen, S., Huang, H., Li, G., Yamahara, J., Roufogalis, B., Li, Y. (2006). Bromelain improves decrease in defecation in postoperative rats: Modulation of colonic gene expression of inducible nitric oxide synthase. Life Sciences, 78(9), 995-1002. [More Information]
  • Aktan, F., Henness, S., Tran, V., Duke, C., Roufogalis, B., Ammit, A. (2006). Gingerol Metabolite and a Synthetic Analogue Capsarol (TM) Inhibit Macrophage NF-kappaB Mediated iNOS Gene Expression and Enzyme Activity. Planta Medica: natural products and medicinal plant research, 72(8), 727-734. [More Information]
  • Huang, H., Li, Y., Razmovski-Naumovski, V., Tran, V., Li, G., Duke, C., Roufogalis, B. (2006). Gypenoside XLIX isolated from Gynostemma pentaphyllum inhibits nuclear factor-kappaB activation via a PPAR-alpha-dependent pathway. Journal of Biomedical Science, 13(4), 535-548. [More Information]
  • Huang, H., Tran, V., Roufogalis, B., Li, Y. (2006). Gypenoside XLIX, a naturally occurring gynosaponin, PPAR-alpha dependently inhibits LPS-induced tissue factor expression and activity in human THP-1 monocytic cells. Toxicology and Applied Pharmacology, 218(1), 30-36. [More Information]
  • Huang, H., Tran, V., Duke, R., Tan, S., Chrubasik, S., Roufogalis, B., Duke, C. (2006). Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-kB activation. Journal of Ethnopharmacology, 104(1-2), 149-155. [More Information]
  • Qi, J., Wang, J., Mandadi, S., Tanaka, K., Roufogalis, B., Madigan, M., Lai, K., Yan, F., Chong, B., Stevens, R., et al (2006). Human and mouse mast cells use the tetraspanin CD9 as an alternate interleukin-16 receptor. Blood, 107(1), 135-142. [More Information]
  • Mandadi, S., Tominaga, T., Numazaki, M., Murayama, N., Saito, N., Armati, P., Roufogalis, B., Tominaga, M. (2006). Increased sensitivity of desensitized TRPV1 by PMA occurs through PKCe-mediated phosphorylation at S800. Pain, 123(1-2), 106-116. [More Information]
  • Roufogalis, B., Duke, C., Tran, V. (2006). Medicinal Uses Of Phenylalkanols And Derivatives. Patent No. 1056700.
  • Huang, H., Yang, Q., Harada, M., Uberai, J., Radford, J., Li, G., Yamahara, J., Roufogalis, B., Li, Y. (2006). Salacia oblonga root improves cardiac lipid metabolism in Zucker diabetic fatty rats: Modulation of cardiac PPAR-a-mediated transcription of fatty acid metabolic genes. Toxicology and Applied Pharmacology, 210(1-2), 78-85. [More Information]
  • Huang, H., Peng, G., Li, G., Yamahara, J., Roufogalis, B., Li, Y. (2006). Salacia oblonga root improves postprandial hyperlipidemia and hepatic steatosis in Zucker diabetic fatty rats: activation of PPAR-alpha. Toxicology and Applied Pharmacology, 210(3), 225-235. [More Information]
  • Holland, M., Panetta, J., Hoskins, J., Bebawy, M., Roufogalis, B., Allen, J., Arnold, J. (2006). The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells. Biochemical Pharmacology, 71(8), 1146-1154. [More Information]

2005

  • Huang, H., Razmovski-Naumovski, V., Salam, N., Duke, R., Tran, V., Duke, C., Roufogalis, B. (2005). A novel LXR-a activator identified from the natural product Gynostemma pentaphyllum. Biochemical Pharmacology, 70(9), 1298-1308. [More Information]
  • Kota, B., Huang, H., Roufogalis, B. (2005). An overview on biological mechanisms of PPARs. Pharmacological Research, 51(2), 85-94. [More Information]
  • Huang, H., Peng, G., Kota, B., Li, G., Yamahara, J., Roufogalis, B., Li, Y. (2005). Anti-diabetic action of Punica granatum flower extract: activation of PPAR and identification of an active component. Toxicology and Applied Pharmacology, 207(2), 160-169. [More Information]
  • Holland, M., Allen, J., Bebawy, M., Roufogalis, B., Arnold, J. (2005). Cannabinoid Modulation of P-Glycoprtein Efflux Activity and Expression (Netherlands). Interantional association for cannabis as medicine conference, The Netherlands: Australian Society of Clinical and experimental Pharmacologists and Toxicologista.
  • Arnold, J., Holland, M., Bebawy, M., Roufogalis, B., Allen, J. (2005). Cannabinoid Modulation of P-Glycoprtein Efflux Activity and Expression (Spain). SOCIEDAD ESPANOLA DE INVESTIGACION SOBRE CANNABINOIDES, Barcelona: Australian Society of Clinical and experimental Pharmacologists and Toxicologista.
  • Razmovski-Naumovski, V., Huang, H., Tran, V., Li, G., Duke, C., Roufogalis, B. (2005). Chemistry and pharmacology of Gynostemma pentaphyllum. Phytochemistry Reviews, 4(3-Feb), 197-219. [More Information]
  • Jiang, X., Williams, K., Liauw, W., Ammit, A., Roufogalis, B., Duke, C., Day, R., McLachlan, A. (2005). Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. British Journal of Clinical Pharmacology, 59(4), 425-432. [More Information]
  • Huang, H., Kota, B., Razmovski-Naumovsk, V., Roufogalis, B. (2005). Herbal or Natural Medicines as Modulators of Peroxisome Proliferated-Activated Receptors and Related Nuclear Receptors for Therapy of Metabolic Syndrome. Basic and Clinical Pharmacology and Toxicology, 96(1), 3-14. [More Information]
  • Megalli, S., Aktan, F., Davies, N., Roufogalis, B. (2005). Phytopreventative anti-hyperlipidemic effects of gynostemma pentaphyllum in rats. Journal of Pharmacy and Pharmaceutical Sciences, 8(3), 507-515. [More Information]
  • Huang, H., Yang, Q., Harada, M., Li, G., Yamahara, J., Roufogalis, B., Li, Y. (2005). Pomegranate Flower Extract Diminishes Cardiac Fibrosis in Zucker Diabetic Fatty Rats: Modulation of Cardiac Endothelin-1 and Nuclear Factor-kappaB Pathways. Journal of Cardiovascular Pharmacology, 46(6), 856-862. [More Information]
  • Huang, H., Peng, G., Kota, B., Li, G., Yamahara, J., Roufogalis, B., Li, Y. (2005). Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids. British Journal of Pharmacology, 145(6), 767-774. [More Information]
  • Li, Y., Wen, S., Kota, B., Peng, G., Li, G., Yamahara, J., Roufogalis, B. (2005). Punica granatum flower extract, a potent a-glucosidase inhibitor, improves postprandial hyperglycemia in Zucker diabetic fatty rats. Journal of Ethnopharmacology, 99(2), 239-244. [More Information]
  • Huang, H., Razmovski-Naumovski, V., Kota, B., Lin, D., Roufogalis, B. (2005). The pathophysiological function of peroxisome proliferator-activated receptor-gamma in lung-related diseases. Respiratory Research, 6(1), 102-1-102-9. [More Information]
  • Chrubasik, S., Pittler, M., Roufogalis, B. (2005). Zingiberis rhizoma: A comprehensive review on the ginger effect and efficacy profiles. Phytomedicine, 12(9), 684-701. [More Information]

2004

  • Mandadi, S., Numazaki, M., Tominaga, M., Bhat, M., Armati, P., Roufogalis, B. (2004). Activation Of Protein Kinase C Reverses Capsaicin-Induced Calcium-Dependent Desensitization Of Trpv1 Ion Channels. Cell Calcium, 35(5), 471-478. [More Information]
  • Fu, D., Bebawy, M., Kable, E., Roufogalis, B. (2004). Dynamic And Intracellular Trafficking Of P-Glycoprotein-EGFP Fusion Protein: Implications In Multidrug Resistance In Cancer. International Journal of Cancer, 109(2), 174-181. [More Information]
  • Pajic, M., Bebawy, M., Hoskins, J., Roufogalis, B., Rivory, L. (2004). Effect Of Short-Term Morphine Exposure On P-Glycoprotein Expression And Activity In Cancer Cell Lines. Oncology Reports, 11(5), 1091-1095.
  • Jiang, X., Williams, K., Liauw, W., Ammit, A., Roufogalis, B., Duke, C., Day, R., McLachlan, A. (2004). Effect Of St John's Wort And Ginseng On The Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects. British Journal of Clinical Pharmacology, 57(5), 592-599. [More Information]
  • Chrubasik, S., Conradt, C., Roufogalis, B. (2004). Effectiveness of Harpagophytum extracts and clinical efficacy. Phytotherapy Research, 18(2), 187-189. [More Information]
  • Fu, D., Roufogalis, B. (2004). Endosomal trafficking of P-Glycoprotein: actin dependence. ABC Transporters Symposium, Sydney.
  • Coxeter, P., McLachlan, A., Duke, C., Roufogalis, B. (2004). Herb-Drug Interactions: An Evidence Based Approach. Current Medicinal Chemistry, 11(11), 1513-1525.
  • Li, Y., Peng, G., Li, G., Wen, S., Huang, H., Roufogalis, B., Yamahara, J. (2004). Salacia Oblonga Improves Cardiac Fibrosis And Inhibits Postprandial Hyperglycemia In Obese Zucker Rats. Life Sciences, 75(14), 1735-1746. [More Information]

2003

  • Huang, H., Kota, P., Li, Y., Goh, P., Roufogalis, B. (2003). Ayurveda: tapping into India's rich anti-diabetic pharmacopoeia. Pharmacy News, , 9-10.
  • Wanigasekara-Mohotti, Y., Armati, P., Roufogalis, B. (2003). Ca2+-ATPase isoforms are expressed in neuroprotection in rat, but not human, neurons. NeuroReport, 14(18), 2421-2424.
  • Fu, D., Roufogalis, B. (2003). Cellular localization of P-gp-EGFP correlates with cytotoxic drug accumulation in cancer cells. Hunter Cellular Biology Meeting, Australia: Cellular Biology Meeting Inc,.
  • Nurtjahja-Tjendraputra, E., Ammit, A., Roufogalis, B., Tran, V., Duke, C. (2003). Effective anti-platelet and cox-1 enzyme inhibitors from pungent constituents of ginger. Thrombosis Research, 111, 259-265. [More Information]
  • Coxeter, P., McLachlan, A., Duke, C., Roufogalis, B. (2003). Garlic-drug interactions. The Journal of Complementary Medicine, 11, 57-59.
  • Coxeter, P., McLachlan, A., Duke, C., Roufogalis, B. (2003). Ginkgo biloba interactions. The Journal of Complementary Medicine, 11, 70-72.
  • Aktan, F., Henness, S., Roufogalis, B., Ammit, A. (2003). Gypenosides derived from gynostemma pentaphyllum suppress no synthesis in murine macrophages by inhibiting inos enzymatic activity and attenuating nf-kb-mediated inos protein expression. Nitric Oxide: Biology And Chemistry, 8(4), 235-242. [More Information]
  • Coxeter, P., McLachlan, A., Duke, C., Roufogalis, B. (2003). Interaction or over-reaction? Journal of Alternative and Complementary Medicine, 11, 60-61.
  • Fu, D., Roufogalis, B. (2003). Intracellular trafficking and recycling of P-glycoprotein-EGFP fusion is actin dependent. 43rd Annual Meeting of the American Society for Cell Biology, USA: American Society for Cell Biology.
  • Coxeter, P., McLachlan, A., Duke, C., Roufogalis, B. (2003). Liquorice-drug interactions. The Journal of Complementary Medicine, 11, 40-43.
  • Fu, D., Roufogalis, B. (2003). Overcoming multidrug resistance by blocking intracellular trafficking of P-glycoprotein in human cancer cells. APSA (Australia Pharmaceutical Science Association) 2003 Conference, Integrating Research into Practice, Australia: Australia Pharmaceutical Science Association.
  • Coxeter, P., McLachlan, A., Duke, C., Roufogalis, B. (2003). St John's wort interactions. Journal of Alternative and Complementary Medicine, 11, 66-68.
  • Li, G., Duke, C., Roufogalis, B. (2003). The quality and safety of traditional Chinese medicines. Australian Prescriber, 26(6), 128-130.

2002

  • Li, G., Duke, C., Roufogalis, B. (2002). An integrative east-west herbal medicine education model in Sydney. First International Symposium on TCM Education.
  • Fu, D., Bebawy, M., Kable, E., Roufogalis, B. (2002). Characterisation and intracellular localisation of P-glycoprotein-EGFP fusion protein. ComBio 2002, Sydney: Australian Society for Biochemistry and Molecular Biology.
  • Roufogalis, B., Dedov, V., Tran, V., Duke, C. (2002). Development of gingerols and synthetic derivatives for pain and inflammation. 5th Australia/Japan Symposium on Drug Design and Development.
  • Dedov, V., Tran, V., Duke, C., Connor, M., Christie, M., Mandadi, S., Roufogalis, B. (2002). Gingerols: a novel class of vanilloid receptor (VR1) agonists. British Journal of Pharmacology, 137(6), 793-798. [More Information]
  • Duke, R., Chebib, M., Duke, C., Johnston, G., Roufogalis, B. (2002). Ginkgo biloba - food for the brain. New Zealand Pharmacy, , 27-33.
  • Qi, J., Stevens, R., Wadley, R., Collins, A., Cooley, M., Naif, H., Nasr, N., Cunningham, A., Katsoulotos, G., Wanigasekara-Mohotti, Y., Roufogalis, B., et al (2002). IL-16 Regulation of Human Mast Cells/Basophils and Their Susceptability to HIV-1. Journal of Immunology, 168(8), 4127-4134.
  • Chrubasik, S., Roufogalis, B. (2002). Phytomedicines for Respiratory Tract Diseases. Australia: Australian Pharmaceutical Publishing COmpany Ltd.
  • Mandadi, S., Armati, P., Roufogalis, B. (2002). Specific translocation of protein kinase cisoforms in rat dorsal root gnaglion neurons and activation of VR-1 polymodal receptors. 10th World Congress on Pain, USA: International Association for the Study of Pain Press.
  • Roufogalis, B. (2002). The growth in complementary and herbal medicine. In Kong Yun-cheung (Eds.), Modern Chinese Medicine: Education , Research and Development, (pp. 19-24). Hong Kong: BMJ Publishing Group.
  • Li, G., Duke, C., Roufogalis, B. (2002). The progress of Chinese medicine in Australia. In Kelvin Chan, Henry Lee (Eds.), the Way Forward for Chinese Medicine, (pp. 173-190). London & New York: BMJ Publishing Group.

2001

  • Li, G., Duke, C., Roufogalis, B. (2001). A new approach to advanced educaiton in herbal medicines established at the University of Sydney. Australian Journal of Chinese Medicine, , 82-84.
  • Duke, C., Goh, P., McLachlan, A., Roufogalis, B. (2001). Complementary Medicines. Australia: Pharmaceutical Society of Australia.
  • Tjendraputra, E., Tran, V., Liu-Brennan, D., Roufogalis, B., Duke, C. (2001). Effect of Ginger Constituents and Synthetic Analogues on Cyclooxygenase-2 Enzyme in Intact Cells. Bioorganic Chemistry, 29(3), 156-163.
  • Tjendraputra, E., Tran, V., Liu-Brennan, D., Roufogalis, B., Duke, C. (2001). Effects of ginger constituents and synthetic analogues on cyclooxygenase-2 enzyme in intact cells. Bioorganic Chemistry, 29(3), 156-163.
  • Brymora, A., Cousin,, M., Roufogalis, B., Robinson, P. (2001). Enhanced Protein Recovery and Reproducibility from Pull-Down Assays and Immunoprecipitations using spin columns. Analytical Biochemistry, 295(1), 119-122.
  • Goh, P., Roufogalis, B. (2001). Feverfew for migrain prophylaxis. Australian Pharmacy Trade, 37224, 1-2.
  • Koo, K., Ammit, A., Tran, V., Duke, C., Roufogalis, B. (2001). Gingerols and related analogues inhibit arachidonic acid-induced human platelet serotonin release and aggregation. Thrombosis Research, 103, 387-397.
  • Goh, P., Roufogalis, B. (2001). Horse chestnut seed extract for CVI. Australian Pharmacy Trade, 37210, 16-17.
  • Li, G., Duke, C., Roufogalis, B. (2001). Innovative approach to education of hebal medicine. Ed-Health, : World Scientific Publishing.
  • Chrubasik, S., Roufogalis, B. (2001). Issues in quality and comparability of herbal medicinal products - part 1. Australian Journal of Pharmacy, 82, May, 444-445.
  • Chrubasik, S., Roufogalis, B. (2001). Issues in quality and comparability of herbal medicinal products - part 2. Australian Journal of Pharmacy, 82, June, 546-548.
  • Chrubasik, S., Roufogalis, B. (2001). Milk thistle fruit for liver diseases. Australian Pharmacy Trade, 37236, 1-2.
  • Chrubasik, S., Roufogalis, B. (2001). Pain relief with herbal antirheumatics. New Zealand Pharmacy, June, 19-24.
  • Bebawy, M., Morris, M., Roufogalis, B. (2001). Selective modulation of P-glycoprotein-mediated drug resistance. British Journal of Cancer, 85(12), 1998-2003.
  • Brymora, A., Roufogalis, B., Robinson, P., Valova, V., Larsen, M. (2001). The brain exocyst complex interacts with RalA in a GTP-dependent manner - Identification of a novel mammalian Sec3 gene and a second Sec15 gene. Journal of Biological Chemistry, 276(32), 29792-29797.
  • Dedov, V., Cox, G., Roufogalis, B. (2001). Visualisation of mitochondria in living neurons with sing;e and two-photon fluorescence laser microscopy. Micron, 32, 653-660. [More Information]
  • Dedov, V., Cox, G., Roufogalis, B. (2001). Visualization of mitochondria in living neurons with single- and two-photon fluorescence laser microscopy. Micron, 32(7), 653-660. [More Information]

To update your profile click here. For support on your academic profile contact .